• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Rapid Diagnostek

edit

Rapid Diagnostek Inc.has developed a patented, inexpensive, easy to use sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Markets of opportunity include human and veterinary diagnostic, environmental, biohazard, bioterrorism, agricultural commodity, and food safety testing. Our technology offers remarkably faster and less expensive results than existing methods. Current diagnostic tests can take hours to days from the time a sample is taken to delivery of results. Rapid Diagnostek’s IntelliProbe Immunosensor™ (IPI™) platform can deliver results at the point of sampling in under 60 seconds. The sensor has performed as intended in the laboratory and the company is now developing a fully functioning device and initial assays to aggressively move towards commercialization.

Recent Milestones

edit

• 
  Rapid Diagnostek received $4M in Series B funding. (1/29/10)
  Posted 1/30/10 at 2:08am via dowjones.com
• 
  Rapid Diagnostek added Harry Norris as President, CEO, Director .
  Posted 1/30/10 at 2:08am
• 
  Rapid Diagnostek added Paul Knapp as Chairman.
  Posted 1/30/10 at 2:08am

Videos

Screenshots

edit

Sources

1. Peak Ridge Ag Fund Makes First Deal, Leads Rapid Diagnostek's $4M Series B (fis.dowjones.com) [edit]